Recruiting
Exploring the Effectiveness of AI Generative Models for Diabetic Patients
We plan to explore the usability of Generative AI-Chatbot for Diabetic Patient
ClinicalTrials.gov IDNCT05883072
PhaseNot Applicable
Enrollment300
SponsorPakistan Council of Scientific and Industrial Research
Age18 Years
SexALL
Conditions studied
Diabetes Mellitus, Type 2, Diabetic Retinopathy, Diabetes
About this study
We plan to explore the usability of Generative AI-Chatbot for Diabetic Patient
Interventions
- Behavioral: Exploring AI-Chatbot — All participants will be provided access to AI-Chatbot and will be asked to enquire their daily life problems related to diabetes. They will also be asked to review the replies of the Chatbot after their interaction.
Primary outcomes
- Usability of the Chatbot for diabetic patient (One time)
- Internet Speed (One time)
Eligibility information
Inclusion Criteria:
* Present physically in Pakistan
* Adults (18 years or older)
* Diabetic Patient
Exclusion Criteria:
* Adults unable to consent
* Individuals who are not yet adults (infants, children, teenagers)
* Prisoners
Study locations
- CDLE, PCSIR Lbas Complex, Karachi, Sindh Pakistan
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.